Australia vs India: Proportion of isolates with decreased susceptibility or resistance
Australia
0.01
in 2020
India
0
in 2020
Australia rank
12th
India rank
13th
Proportion of isolates with decreased susceptibility or resistance over time
- Australia
- India
How they compare
Australia currently reports 0.01 against 0 in India, a difference of 0.01.
The two have swapped places 5 times across 11 shared years of data; in 2009 it was India ahead.
Australia ranks 12th and India ranks 13th of 52 countries.
Across the 3 decades both report, Australia averaged higher in 1 and India in 2.
Head to head by decade
| Decade | Australia | India | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0317 | 10.81 | 10.78 | India |
| 2010s | 0.4001 | 3.65 | 3.25 | India |
| 2020s | 0.01 | 0 | 0.01 | Australia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Australia or India?
- Australia, at 0.01 against 0 in India as of 2020.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Australia and India?
- 0.01, with Australia ahead.
- How many years of comparable data are there for Australia and India?
- 11 years are reported by both, from 2009 to 2020.
- How do Australia and India rank globally for proportion of isolates with decreased susceptibility or resistance?
- Australia ranks 12th and India ranks 13th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.